Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA

Podiatry Arena Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

3rd May 2011, 03:30 PM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,129

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

Tradjenta (linagliptin) Tablets For Diabetes Type 2 Approved By FDA

Podiatry Arena members do not see these ads

The FDA has approved Tradjenta (linagliptin) tablets to control blood sugar in adults with diabetes type two - to be used along with diet and exercise, Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly announced today. Tradjenta can be used on its own or together with metformin, sulfonylurea or pioglitazone. Linagliptin was shown to reduce hemoglobin A1C (HbA1C or A1C) levels up to 0...

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
FDA Approves Linagliptin Tablets For The Treatment Of Type 2 Diabetes	RSSFeedBot	Latest Diabetes Medicine Research & News	0	3rd May 2011 06:11 AM
Kombiglyze? Xr (Saxagliptin And Metformin Hcl Extended-Release) Tablets Approved In The U.S. For The Treatment Of Type 2 Diabetes Mellitus In Ad	RSSFeedBot	Latest Diabetes Medicine Research & News	0	8th November 2010 09:40 AM
Phase III Trials Show Linagliptin Effectively Reduces Blood Glucose, With Good Tolerability	RSSFeedBot	Latest Diabetes Medicine Research & News	0	28th June 2010 10:30 AM
FDA-approved drug may slow beta cell destruction in type 1 diabetes patients	RSSFeedBot	Latest Diabetes Medicine Research & News	0	4th December 2009 03:30 PM
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes	RSSFeedBot	Latest Diabetes Medicine Research & News	0	31st October 2009 06:10 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 11:30 AM.

User Name		Remember Me?
Password